Fundraising FoxFood and Drug Administration (FDA) — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Functional Fluidics is a CLIA-certified diagnostic lab offering proprietary red blood cell function biomarker assays, starting with Sickle Cell Disease.
BiotechDigital HealthHealthtechMedical DevicesDetroit, US
Patrick Hines(CEO & Founder)inDr. Hines(Founder)John Cunningham(Chief Operating Officer)in
Co-investorsID VenturesMichigan RiseNYBC VenturesResilient VenturesSeae VenturesWavemaker Three-Sixty Health
Nanohmics performs collaborative and client-funded research and advanced product development in applied materials science and instrumentation, building novel sensing devices and measurement platforms for applications such as surveillance, detection, and energy conversion.
CleantechDeep TechDefense TechEnterprise SoftwareHardwareNew MaterialsSemiconductors
RPRD is a CAP- and CLIA-certified laboratory that develops and offers pharmacogenomic (PGx) testing designed to be inclusive across races and ethnicities, helping clinicians tailor drug prescriptions to a patient's genetic profile.
BiotechDigital HealthHealthtech
Ulrich Broeckel(Founder and CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.